DK1187611T3 - Oftalmiske histaminholdige sammensætninger og anvendelse deraf - Google Patents

Oftalmiske histaminholdige sammensætninger og anvendelse deraf

Info

Publication number
DK1187611T3
DK1187611T3 DK00939556T DK00939556T DK1187611T3 DK 1187611 T3 DK1187611 T3 DK 1187611T3 DK 00939556 T DK00939556 T DK 00939556T DK 00939556 T DK00939556 T DK 00939556T DK 1187611 T3 DK1187611 T3 DK 1187611T3
Authority
DK
Denmark
Prior art keywords
ophthalmic
histamine
containing compositions
concentration
pharmaceutically acceptable
Prior art date
Application number
DK00939556T
Other languages
English (en)
Inventor
Kurt R Gehlsen
Original Assignee
Maxim Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxim Pharm Inc filed Critical Maxim Pharm Inc
Application granted granted Critical
Publication of DK1187611T3 publication Critical patent/DK1187611T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
DK00939556T 1999-06-03 2000-06-02 Oftalmiske histaminholdige sammensætninger og anvendelse deraf DK1187611T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13756499P 1999-06-03 1999-06-03

Publications (1)

Publication Number Publication Date
DK1187611T3 true DK1187611T3 (da) 2004-10-11

Family

ID=22478011

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00939556T DK1187611T3 (da) 1999-06-03 2000-06-02 Oftalmiske histaminholdige sammensætninger og anvendelse deraf

Country Status (11)

Country Link
US (1) US6531120B2 (da)
EP (1) EP1187611B1 (da)
AT (1) ATE273704T1 (da)
AU (1) AU777655B2 (da)
CA (1) CA2376108A1 (da)
DE (1) DE60013126T2 (da)
DK (1) DK1187611T3 (da)
ES (1) ES2225156T3 (da)
HK (1) HK1045458B (da)
PT (1) PT1187611E (da)
WO (1) WO2000074649A2 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4316238B2 (ja) 2001-02-28 2009-08-19 メルク エンド カムパニー インコーポレーテッド メラノコルチン−４受容体作動薬としてのアシル化ピペリジン誘導体
SK286917B6 (sk) 2001-02-28 2009-07-06 Merck & Co., Inc. 4-Substituované N-acylované deriváty piperidínu, farmaceutický prípravok s ich obsahom a ich použitie
EP1411940B1 (en) 2001-07-18 2008-10-15 Merck & Co., Inc. Bridged piperidine derivatives as melanocortin receptor agonists
CA2480047A1 (en) * 2002-03-29 2003-10-09 Maxim Pharmaceuticals, Inc. Use of rom production and release inhibitors to treat and prevent intraocular damage
JP2006505531A (ja) 2002-09-11 2006-02-16 メルク　エンド　カムパニー　インコーポレーテッド メラノコルチン−４受容体作働薬としてのピペラジン尿素誘導体
US7071211B2 (en) * 2002-09-27 2006-07-04 Bausch & Lomb Inc. Small organic molecules that increase the activity of gelatinase a in ocular cells
EP1578799B8 (en) * 2002-12-02 2011-03-23 Amgen Fremont Inc. Antibodies directed to tumor necrosis factor and uses thereof
DE10312140B4 (de) * 2003-03-19 2006-10-05 Johnson Controls Gmbh Feststell- und Neigungsverstellvorrichtung für Beschläge
US20040248959A1 (en) * 2003-04-30 2004-12-09 Bender Scott C. Histamine containing eye drops for visual identification of lymphoid tissue within the tissues of the eye, that are to be samples for further diagnostic testing
JP4834829B2 (ja) * 2005-03-31 2011-12-14 国立大学法人山口大学 クラミジア属細菌の抑制に効果のあるトリプトファン代謝中間産物
WO2010020052A1 (en) * 2008-08-21 2010-02-25 Edouard Kouassi Methods and compounds for increasing red blood cell survival
CN104337760B (zh) * 2013-08-02 2018-09-04 山东新时代药业有限公司 一种二盐酸组胺注射液及其制备方法
CN110075063A (zh) * 2019-05-27 2019-08-02 合肥亿帆生物医药有限公司 一种二盐酸组胺注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4510145A (en) * 1980-12-02 1985-04-09 Schachar Ronald A Method for inhibiting contraction of ophthalmic wounds or incisions
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
IL101441A (en) 1992-04-01 1999-07-14 Univ Ramot Pharmaceutical preparations for the treatment and prevention of diseases or irregularities in the eye
EP0642332B1 (en) 1992-05-13 1997-01-15 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
US5401327A (en) 1993-06-18 1995-03-28 Wilmington Partners L.P. Method of treating contact lenses
US5545617A (en) * 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
WO1995023601A1 (en) * 1994-03-02 1995-09-08 Professional Pharmaceutical, Inc. Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
US5861148A (en) 1995-01-23 1999-01-19 Smith; Stewart Gregory Ophthalmic compositions and process of using
US5895645A (en) 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US6071942A (en) * 1996-05-14 2000-06-06 Maxim Pharmaceuticals, Inc. Elevation of circulating blood histamine levels
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
WO1998018458A1 (en) * 1996-10-31 1998-05-07 Alcon Laboratories, Inc. Opthalmological compositions containing serotonin 5-ht1a receptor agonist and their use in the treatment of glaucoma
US5800807A (en) 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
US6270781B1 (en) * 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Also Published As

Publication number Publication date
EP1187611B1 (en) 2004-08-18
EP1187611A2 (en) 2002-03-20
DE60013126T2 (de) 2005-09-08
AU5462700A (en) 2000-12-28
AU777655B2 (en) 2004-10-28
ATE273704T1 (de) 2004-09-15
US6531120B2 (en) 2003-03-11
WO2000074649A3 (en) 2002-01-17
CA2376108A1 (en) 2000-12-14
US20020098224A1 (en) 2002-07-25
WO2000074649A2 (en) 2000-12-14
PT1187611E (pt) 2004-10-29
DE60013126D1 (de) 2004-09-23
HK1045458A1 (en) 2002-11-29
HK1045458B (zh) 2005-03-24
ES2225156T3 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
AU2003301020A1 (en) Isoquinolinone derivatives and their use as therapeutic agents
MY129356A (en) Electrospun pharmaceutical compositions
SE9504661D0 (sv) New compounds
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
DK1187611T3 (da) Oftalmiske histaminholdige sammensætninger og anvendelse deraf
MX9707453A (es) Derivados de quinazolina.
AU2003225617A1 (en) Thiadiazolylpiperazine derivatives useful for treating or preventing pain
MY106259A (en) 2-aminopyrimidinone derivatives.
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
TR200102977T2 (tr) Yeni tedavi yöntemi.
GEP20033079B (en) Pharmaceutical Compositions for Treatment of Diseases Caused by Estrogens Deficiency
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
SE9903997D0 (sv) New compounds
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
ES2194055T3 (es) Nuevo uso de prostaglandinas.
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
NZ237309A (en) 1-(2-(4-morpholino)ethyl)-3-(arylcarbonyl)-indole derivatives and pharmaceutical compositions
NZ514558A (en) Viral treatment
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
MXPA01008993A (es) Tratamiento de combinacion para depresion y ansiedad.
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
MY141012A (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
AU2001278708A1 (en) Adenosine derivatives and use thereof
IL126725A0 (en) Compositions comprising a nitrone compound for use in treating ocular inflammation